MLL1:EZH2 Ratio in Uterine Secretions and Endometrial Receptivity in Patients with Endometriosis
article
OA: closed
CC0
Abstract
OBJECTIVE: To establish a novel approach for diagnosing endometriosis (EM) in patients with impaired endometrial receptivity. METHOD: Mixed lineage leukemia 1 (MLL1) and enhancer of zeste homolog 2 (EZH2) levels were analyzed. The MLL1:EZH2 ratio in identifying impaired endometrial receptivity has been established and validated. RESULTS: In normal endometrial tissue, the MLL1:EZH2 ratio increased significantly in the midsecretory phase, compared with that in the proliferative phase. In the midsecretory phase, the MLL1:EZH2 ratio in endometrial tissues and uterine secretions accurately identifies patients with EM who have impaired endometrial receptivity. In the validation group, the sensitivity and specificity of the MLL1:EZH2 ratio in the uterine secretions of the midsecretory phase, in diagnosing patients EM who have impaired endometrial receptivity, were 100% and 96.55%, respectively. CONCLUSIONS: The MLL1:EZH2 ratio in uterine secretions of the midsecretory phase may serve as a marker to diagnose EM in patients with impaired endometrial receptivity.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Association between ovarian endometrioma and ovarian reserve via openalex
- Decreased mixed lineage leukemia 1 is involved in endometriosis-related infertility via openalex
- Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches via openalex
- Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options via openalex
- Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle via openalex
- Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- W2951136679 via openalex
- W2992063293 via openalex
- W2996101359 via openalex
- W3008594685 via openalex
- W3014674233 via openalex
- W3045753156 via openalex
- W2108959969 via openalex
- W4210400114 via openalex
- W2114673109 via openalex
- W2169681344 via openalex
- W2173213419 via openalex
- W2413716016 via openalex
- W2751357516 via openalex
- W2773702346 via openalex
- W2910025422 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:34:36.779044+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK